BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35876924)

  • 1. Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells.
    Kimura Y; Tsunedomi R; Yoshimura K; Matsukuma S; Shindo Y; Matsui H; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
    Ann Surg Oncol; 2022 Nov; 29(12):7423-7433. PubMed ID: 35876924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.
    Nishiyama M; Tsunedomi R; Yoshimura K; Hashimoto N; Matsukuma S; Ogihara H; Kanekiyo S; Iida M; Sakamoto K; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Ueno T; Hamamoto Y; Hazama S; Nagano H
    Cancer Sci; 2018 Apr; 109(4):1101-1109. PubMed ID: 29417690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells.
    Tsunedomi R; Yoshimura K; Kimura Y; Nishiyama M; Fujiwara N; Matsukuma S; Kanekiyo S; Matsui H; Shindo Y; Watanabe Y; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
    BMC Cancer; 2022 Mar; 22(1):260. PubMed ID: 35277124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
    Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs.
    Hashimoto N; Tsunedomi R; Yoshimura K; Watanabe Y; Hazama S; Oka M
    BMC Cancer; 2014 Sep; 14():722. PubMed ID: 25260650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
    Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
    J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
    Shin S; Kim M; Lee SJ; Park KS; Lee CH
    Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function.
    Jiang W; Zhang C; Tian Z; Zhang J
    Gene Ther; 2013 Nov; 20(11):1062-9. PubMed ID: 23759701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells.
    Li D; Sun FF; Wang D; Wang T; Peng JJ; Feng JQ; Li H; Wang C; Zhou DJ; Luo H; Fu ZQ; Zhang T
    Oncol Res; 2020 Dec; 28(5):467-481. PubMed ID: 32560747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
    Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
    Qin WH; Yang ZS; Li M; Chen Y; Zhao XF; Qin YY; Song JQ; Wang BB; Yuan B; Cui XL; Shen F; He J; Bi YF; Ning G; Fu J; Wang HY
    Gastroenterology; 2020 May; 158(6):1713-1727. PubMed ID: 31972238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
    Fang L; Gong J; Wang Y; Liu R; Li Z; Wang Z; Zhang Y; Zhang C; Song C; Yang A; Ting JP; Jin B; Chen L
    J Exp Clin Cancer Res; 2014 Sep; 33(1):76. PubMed ID: 25228093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma.
    Kim KY; Kang MA; Nam MJ
    Cancer Lett; 2001 May; 166(1):33-40. PubMed ID: 11295284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing efficiency affected by mutually modulated PD-1 and PD-L1 expression via NKT-hepatoma cell interactions.
    Liu L; Yang M; Xu Q; Zhou M; Cheng Y; Xu H; Qin Y; Liu B
    Immunotherapy; 2021 Feb; 13(2):113-123. PubMed ID: 33076728
    [No Abstract]   [Full Text] [Related]  

  • 19. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B.
    Lee HH; Kim D; Jung J; Kang H; Cho H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.